Login / Signup

Impact of remission and low disease activity on health-related quality of life in patients with systemic lupus erythematosus.

Sharzad EmamikiaShereen OonAlvaro GomezJulius LindblomAlexander BorgYvonne EnmanEric F MorandDavid GrannasRonald F van VollenhovenMandana NikpourIoannis Parodis
Published in: Rheumatology (Oxford, England) (2022)
Remission and LLDAS contribute to a HRQoL benefit in a time-dependent manner. Shorter time in remission than in LLDAS was required for a clinically important benefit in HRQoL, and longer time in remission for a benefit in mental compared with physical HRQoL aspects. When remission/LLDAS was sustained, the same benefit was achieved in a shorter time.
Keyphrases
  • disease activity
  • systemic lupus erythematosus
  • rheumatoid arthritis
  • rheumatoid arthritis patients
  • ankylosing spondylitis
  • juvenile idiopathic arthritis
  • ulcerative colitis
  • mental health
  • physical activity